(Q46836012)
Statements
1 reference
A phase I and pharmacokinetic study of a powder-filled capsule formulation of oral irinotecan (CPT-11) given daily for 5 days every 3 weeks in patients with advanced solid tumors (English)
1 reference
Henry C Pitot
1 reference
Alex A Adjei
1 reference
Charles Erlichman
1 reference
Pamela J Atherton
1 reference
Steven R Alberts
1 reference
Joel M Reid
1 reference
Jeff A Sloan
1 reference
Joseph Rubin
1 reference
Barbara A Duncan
1 reference
Louis Denis
1 reference
Larry J Schaaf
1 reference
Donghua Yin
1 reference
Amarnath Sharma
1 reference
Patrick McGovren
1 reference
Langdon L Miller
1 reference
19 November 2005
1 reference
58
1 reference
2
1 reference
165-172
1 reference